3SOF

Current stock Price $0.41, total share out 30.2Million
2002 rev.12.64M net Profit 6.81M
2003 Revenue 15.495M Net Profit 6.41M
2004 Revenue16.835M  Net Profit 4.232M=0.14/share
first half 2005 Revenue 12.232M net Inc.194M vs 1st half 2004  Rev.6.14M net Inc.1.02M

ETLT prices plummeted dure to thei profit shrinked while their sheep embryo business disappeared. However, with the Company Annuncing on June 7,2005
" that the company has signed contracts that represent $15, 974,688 in revenue year to date. The income generated from these contracts is expected to significantly exceed all of the income generated in 2004. Management expects to sign additional contracts throughout the third and fourth quarters."
I think the company has succeesfully gained new business and profit will starting to grow again. With a trailing PE of 3, and much more cash/share than its stock price,this stock will have to rocket to the skies.

Eternal Technologies Group, Inc. (OTCBB: ETLT) traded as much as 14% over Wednesday's close in early trading on Thursday.

Eternal Technologies Group, Inc. is a major agricultural genetics and biopharmaceutical R&D firm operating in China with the support of the Chinese Government. Eternal's animal breeding division has a strong asset base, cash position and net income. Eternal has become one of China's leading institutions for biopharmaceutical and biotech research, pure breed cultivation and breed stock production. The Company has secured a key market niche by commercializing gene engineering technologies and providing superior breeding stock, allowing China's citizens the ability to improve their living standards.


I posted   CXTI a couple of weeks ago, when it was under a $1, now it has made new highs, to $3.30.

This stock could have the same potential.  Keep on watch.

have you seen the news today, Expansion at home and the US.

The NAV is about USD1.25 and cash backing at 80c or more
This could earn about 25-30 cents in the next twelve months and clearly has AMBITIOUS plans.

This could represent a massive bargain at 50c ??
Views

Sav

are you still in there with ETLT

IMO 2H could be explosive... no?
LJ8

ETLT Summarization and TA analysis link:
http://harbinus.blogspot.com/2005/10/eternal-technologies-group-etltotcbb.html
(from Alex Harbin)

I strongly support Alex Harbins analysis  ;)

ETLT Profile; Pro & Con:

Knobias, Inc. Announces Eternal Technologies Group Inc. as the SPOT of the Week in Its Small-Cap ClipReport
Tuesday October 4, 11:58 am ET

RIDGELAND, Miss., Oct. 4, 2005 (PRIMEZONE) -- Knobias, Inc. (OTC BB:KNBS.OB - News) announced today that it has selected Eternal Technologies Group Inc. (OTC BB:ETLT.OB - News) as the SPOT of the week in the Knobias Small-Cap ``ClipReport.''

Eternal Technologies Group Inc. is an agricultural genetics and animal husbandry company operating in China with the support of the Chinese Government. The company uses advanced breeding techniques and markets fine breed animal embryos, breeding stock and breeding services to develop larger, stronger and healthier livestock. The company began to sell lamb meat and transfer dairy cattle embryos in 2003.

The Bulls say:
-If ETLT were a U.S. company, you'd expect it to be trading at 15-20 times earnings, or $2.40-3.20 per share. Surely ETLT would be trading, at the very least, equal to ``cash'' or $0.75 per share. Instead, despite double-digit growth, ETLT trades at an unheard of 2.99 trailing P/E and is valued at nearly half of cash on hand.

The Bears say:
-ETLT reports a cash balance of $21.3 million, 1.46x its market cap. The only problem is that over 95% of it is ``arbitrarily restricted by management for certain uses within the People's Republic of China.'' Therefore, expansion plans outside the PRC must be funded through stock sales (dilution) or borrowing.

Technical Analysis (quoted from the blog Link!):

ETLT broke out of a 2-year bearish trend in the middle of August 2005, this break out is marked on the 1-year chart, and the downtrend may be seen on the 2-year chart. This breakout was very rapid and reached resistance in the high $0.50's.
In the immediate term, ETLT has entered a phase of consolidation. After such a long downtrend, many long-term holders who have been burned by ETLT are exiting after the uptrend.One may note that on the 3-month chart that since the end of August we have been entering a period of lower highs and higher lows. A bullish triangle formation is present and the price is declining slightly on low volume as the last of those who want to exit at this level are doing so. The near and long term resistance levels are in the $0.52 – $0.60 range, as can be seen in all of the charts. A move above this resistance level would signal a breakout and significantly higher highs. A good entry point would be close to the support level at $0.40-$0.45. This support level is fairly strong, it has been tested twice and has held for 2 months. One my also notice from the 1-year and 2-year charts that it looks as though a bullish inverse head and shoulders formation is present and the right shoulder is continuing to develop. A number of future catalysts could propel the stock to higher highs.




feedback always appreciated....

Looks like you have got a nice pick here la-onda ! ;)  "Applaud"
From what I can see looking at the chart.
Symmetrical Triangle (Continuation) Pattern, IMHO....Need a nice Breakout to the upside.

Support @ 0.50...0.49...0.48
Resistance @ 0.54...0.57
MACD is bearish
Stochastic is neutral

Recent CandleStick Analysis
Bearish........As always we need for futher conformation.
Nov-04-2005 Hammer 
Nov-01-2005 Bullish Engulfing 
Oct-31-2005 Bullish Harami 

Technicals
Last Price Quote is:
5.59%above 13-day EMA
14.81%above 50-day EMA

The symmetrical triangle, which can also be referred to as a coil, usually forms during a trend as a continuation pattern. The pattern contains at least two lower highs and two higher lows. When these points are connected, the lines converge as they are extended and the symmetrical triangle takes shape. You could also think of it as a contracting wedge, wide at the beginning and narrowing over time.

While there are instances when symmetrical triangles mark important trend reversals, they more often mark a continuation of the current trend. Regardless of the nature of the pattern, continuation or reversal, the direction of the next major move can only be determined after a valid breakout.

Edwards and Magee suggest that roughly 75% of symmetrical triangles are continuation patterns and the rest mark reversals. The reversal patterns can be especially difficult to analyze and often have false breakouts. Even so, we should not anticipate the direction of the breakout, but rather wait for it to happen. Further analysis should be applied to the breakout by looking for gaps, accelerated price movements, and volume for confirmation. Confirmation is especially important for upside breakouts.

Prices sometimes return to the breakout point of apex on a reaction move before resuming in the direction of the breakout. This return can offer a second chance to participate with a better reward to risk ratio. Potential reward price targets found by measurement and parallel trend line extension are only meant to act as rough guidelines. Technical analysis is dynamic and ongoing assessment is required.

Thanks la-onda

I watched also after the Knobias mention and had read about the in the past.

It has longer term resistance at 0.60 so a close above there on good volume could make it a nice play to hold a while. Seems it can be bought here also as support is close and volume suggests the upside short term

Thanks or pointing it out



(http://img238.imageshack.us/img238/5467/etlt04112ct.jpg)

2005-11-07 09:00:03 

Eternal Technologies Group's ''Breeding Base of Fine American Dairy Cattle'' Completed First Step with Success 

Business Editors / Biotech Writers

HOUSTON--(BUSINESS WIRE)--Nov. 7, 2005--
Eternal Technologies Group, Inc. (OTCBB:ETLT) a leader
in the cattle embryo-transfer industry has successfully completed
phase one of building a breeding base of fine American dairy cattle in
China. During phase one, 2,000 yellow cows were purchased and
transferred to farming facilities where they will be used as host
animals for dairy-cow embryo transfers. The purchase of these 2,000
head of cattle marks a major milestone in the strategic growth of the
company and is one of the initial investments in a 37 million US
dollars investment program. To date, all of the cattle have been
registered, documented, and branded. The purchased cattle were culled
from a pool of approximately 6,000 candidates and were chosen for
their physical condition, adaptability and history of successful
gestation and reproduction.
By using the comparatively inexpensive domestic yellow cow as
surrogate mothers to produce thoroughbred dairy cattle on a mass
scale, the company will be able to decrease its production cost, and
reconfirm its leading position in the embryo transplantation industry.
The cost of a yellow cow is approximately one quarter of that of a
dairy cow, and each surrogate yellow cow is capable of undergoing
multiple transplantations. While the time required for the
reproduction cycle of breeding cattle is fixed, the method used by
ETLT to introduce dairy cattle into mainland China is both a practical
and efficient method of accelerating the proliferation of fine dairy
cattle. This will be a key factor in facilitating ETLT's growth. ETLT
is now scheduling the technical resources for the transfer cycle.
ETLT estimates that the surrogate cattle will deliver pedigree
Holstein heifer calves in September 2006. After a three-month period,
the calves will be distributed to dairy producers across the country
to ease the shortage of quality dairy cattle in China.
As a complementary project ETLT is establishing an "embryo
production laboratory for the production of fine dairy cows." This is
another integral part of the company's strategic plan as well as the
establishment of operations in the U.S.

up 16%  ;D

BO in my opinion, I am in @ 0.63 $

Quote from: setravis on November 06, 2005, 09:35:15 PM
Looks like you have got a nice pick here la-onda ! ;) "Applaud"
From what I can see looking at the chart.
Symmetrical Triangle (Continuation) Pattern, IMHO....Need a nice Breakout to the upside.

Quote from: la-onda on November 07, 2005, 10:34:34 AM
BO in my opinion, I am in @ 0.63 $

I'll buy that....I'm in with you my friend....@ 0.63
Nice pick applaud.....   ;)      I had my eye on it since you posted it yesterday.
Let's rock an roll !!!! ;D

Great !!!
Price breakout resistance at 0.58 !!!

fundamentals :
Eternal Technologies Group, Inc. (OTCBB:ETLT) a leader in the cattle embryo-transfer industry has successfully completed phase one of building a breeding base of fine American dairy cattle in China. During phase one, 2,000 yellow cows were purchased and transferred to farming facilities where they will be used as host animals for dairy-cow embryo transfers. The purchase of these 2,000 head of cattle marks a major milestone in the strategic growth of the company and is one of the initial investments in a 37 million US dollars investment program. To date, all of the cattle have been registered, documented, and branded. The purchased cattle were culled from a pool of approximately 6,000 candidates and were chosen for their physical condition, adaptability and history of successful gestation and reproduction.

By using the comparatively inexpensive domestic yellow cow as surrogate mothers to produce thoroughbred dairy cattle on a mass scale, the company will be able to decrease its production cost, and reconfirm its leading position in the embryo transplantation industry. The cost of a yellow cow is approximately one quarter of that of a dairy cow, and each surrogate yellow cow is capable of undergoing multiple transplantations. While the time required for the reproduction cycle of breeding cattle is fixed, the method used by ETLT to introduce dairy cattle into mainland China is both a practical and efficient method of accelerating the proliferation of fine dairy cattle. This will be a key factor in facilitating ETLT's growth. ETLT is now scheduling the technical resources for the transfer cycle.

technicals :
breakout...

To all in this stock,
Just want to give an example of one of my trading strategies. Look at bottom chart that la-onda posted at the very bottom you will see the 20 day MA and the MACD that's what I use have crossed  above the 20day line also look how the volume increases up or down as each buy and sell signal is given I consider that the buy signal line crosses above the MA and when it crosses back below it that is the sell signal The reason why I'm saying this is the buy signal was given before now which if you had entered when the buy signal was given you would have better profits. I call this MOM/MA trading. Movin on momentum/28 day moving average. I like using 28 days. Also when useing this system you might consider waiting a one or two days to buy to make sure it's not a fake signal to buy but I also search for some reason for the rise and if I see some I will usually go aheah and buy when the signal is given.
Good luck trading to all :)

was a nice pick - I had a little from last week but would have missed adding more in time today without your post

Thanks

thanks for the applaud & feedback setravis & metro, I am also appreciating all your posts and analysis!

cheers
OLIVER

updated chart:

I applaud you la-onda
It looks like you might have a winner here, hope you rake in a big win.
Good luck trading :)

Great pick Oliver. I got in this morning before the run up. Thanks again.

updated chart, holding well IMO

Nice pick Oliver.  :o

I very much like the sector and the blog was very convincing.  How do you find statistics on this company? (Yahoo lists almost nothing.) 

Also, I noticed that this stock was priced @ $15 in IPO.  Did this stock used to be on the Nasdaq or another large exchange?  I kinda fee that a company that was originally on Naz or NYSE that fell to penny stock status has more legitimacy.  At least you can be pretty sure that they are not a scam.

Thanks.

Hi logocovet,

I have found the following links:
http://www.empirerelations.com/news/etlt/index.shtml

http://biz.yahoo.com/ic/115/115508.html

http://www.nasdaq.com/asp/quotes_sec.asp?mode=&kind=&timeframe=&intraday=&charttype=&splits=&earnings=&movingaverage=&lowerstudy=&comparison=&index=&symbol=etlt&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&FormType=&mkttype=&pathname=&page=filings&selected=ETLT

http://www.primezone.com/newsroom/news.html?d=87295

http://www.seomarketwire.com/0505/20050513T123000Z-086663.html



hope this helps

Oliver

updated chart:

Link:
http://www.stockta.com/cgi-bin/analysis.pl?symb=ETLT&num1=3&cobrand=&mode=stock

any TA feedback?

nice answer from the market today:

Quote from: la-onda on November 10, 2005, 05:55:43 PM
nice answer from the market today:

Wasn't it though !!  :o
la-onda , "You' get some "extra applaud" from me for finding this nice little puppy ! ;)
You went on a great hunt.... ;D Came back with a full bag... :D
IMHO, I think this little baby will pick up momentum over the next few weeks.
The company has good revenues, and even bigger cash reserves. They pretty much have enough cash to buy back every share!
We should see more and more interest, ETLT is going to be a major player in their field.
Huge, wide open market.
Symmetrical Triangle (Continuation) Pattern
That was a great breakout and follow through from the pattern.Just what we needed !  :o

Support @ 0.65...0.57...0.54...0.50
MACD is Bullish
Stochastic is Bullish

Technicals
Percentage Gainer

Last Price Quote is:
34.95%above 13-day EMA
55.37%above 50-day EMA

Thanks Oliver,

for all the info (and your prior AE help).  Applause.

I will establish a position in ETLT @ the open tomorrow after I sell my HEB postion (have to cut down on the bird flu plays).

This company definately deserves to get out of penny status.  Lets hope it does!  ;D

Very nice pick Oliver! ;D Applause! ;D

I had been eyeing it since it was posted....but, didn't get in as I should have. :(

But, you think it has more to go....Setravis seems to think so...thats good to know :)

Do u expect a pullback tomorrow...I always seem to be buying at the high, if there is a pullback I would rather wait...any suggestions?

thanks very much...good luck to all!

julia

Quote from: gmarc66 on November 10, 2005, 09:30:41 PM
Very nice pick Oliver! ;D Applause! ;D

I had been eyeing it since it was posted....but, didn't get in as I should have. :(

But, you think it has more to go....Setravis seems to think so...thats good to know :)

Do u expect a pullback tomorrow...I always seem to be buying at the high, if there is a pullback I would rather wait...any suggestions?

thanks very much...good luck to all!

julia

hi julia,
I am totally agreeing with setravis, I will add some shares at the opening.
Pullback?
Could be but as setravis pointed out, the potential is huge

TA link:
http://www.stockta.com/cgi-bin/analysis.pl?symb=ETLT&num1=3&cobrand=&mode=stock
Just my opinion
Oliver

very interesting:

http://www.eternaltechs.com/

&

2nd Quarter analysis:

http://yahoo.brand.edgar-online.com/doctrans/finSys_main.asp?formfilename=0001026700-05-000085&nad=%20

8)
cheers
OLIVER

Oliver,

OT, I know you are into AE.  What do you think about Sunpower? they are coming out with an IPO next week.  There is a thread named IPO's partying like its 1999 where we are talking about it.  I'd appreciate your input.

Quote from: logocovet on November 12, 2005, 02:07:04 AM
Oliver,

OT, I know you are into AE.  What do you think about Sunpower? they are coming out with an IPO next week.  There is a thread named IPO's partying like its 1999 where we are talking about it.  I'd appreciate your input.

Hi logocovet,
I am not invested yet in AE.
Which Sunpower do you mean? After googling there are ore than 1 company listed?
Did you also ask cumulina?
cheers
Oliver

upddated chart

Oliver,

This is the IPO site for Sunpower.  There is also a  link to their website.

http://www.ipohome.com/common/ipoprofile.asp?ticker=SPWR (http://www.ipohome.com/common/ipoprofile.asp?ticker=SPWR)

About ETLT.  I agree that this stock seems undervalued.  However, if we are to agree that the market is always right, there has to be a reason for this.  I don't think it is just because their cash is earmarked to domestic use.  During my research, I've noticed that the company's earnings have gone down over the last 3 years.  The pps has also been in a long downtrend.  Do you know what accounted for this?  And what fundamental factor is accounting for the sudden breakout now?  Thanks. 

I would appreciate anyone's input on this.

Quote from: logocovet on November 14, 2005, 11:35:59 PM
Oliver,

This is the IPO site for Sunpower.  There is also a  link to their website.

http://www.ipohome.com/common/ipoprofile.asp?ticker=SPWR (http://www.ipohome.com/common/ipoprofile.asp?ticker=SPWR)

About ETLT.  I agree that this stock seems undervalued.  However, if we are to agree that the market is always right, there has to be a reason for this.  I don't think it is just because their cash is earmarked to domestic use.  During my research, I've noticed that the company's earnings have gone down over the last 3 years.  The pps has also been in a long downtrend.  Do you know what accounted for this?  And what fundamental factor is accounting for the sudden breakout now?  Thanks. 

I would appreciate anyone's input on this.

logcovet; unfortunately I am very busy @ work, so earliest time would be the weekend to analyse this IPO.

Form 10QSB for ETERNAL TECHNOLOGIES GROUP INC


--------------------------------------------------------------------------------

15-Nov-2005

Quarterly Report



Item 2. Management's Discussion and Analysis or Plan of Operation
The Company's business is seasonal. Accordingly, the results of operations for the three and nine month periods ended September 30, 2005 are not indicative of the results for any other quarter, period or for the fiscal year.

The following is derived from, and should be read in conjunction with, our unaudited condensed consolidated financial statements, and related notes, as of and for the three and nine months ended September 30, 2005 and 2004.

Three Months Ended September 30, 2005 Compared to the Three months Ended September 30, 2004

Revenues -

Revenues for the three months ended September 30, 2005 decreased by $4,047,683 or 44.6% to $5,026,968 from $9,074,651 for the corresponding period of the prior year. This decrease resulted from a decrease in the sale of lamb meat of $2,877,600, in cattle embryo transfers of $1,518,951 and the sale of sheep of $92,723 which was partially offset by an increase in sheep embryo transfers of $441,609.

Cost of Sales -

Cost of sales for the three months ended September 30, 2005 decreased by $2,251,681 to $3,512,402 from $5,764,096 for the corresponding period of the prior year. This decrease resulted from a decrease in the costs of lamb meat of $2,049,236 of cattle embryo transfers of $461,730 and sheep purchases of $108,723 which was partially offset by an increase in sheep embryo transfer costs of $368,008. The gross profit margin from the sale of mutton was 28.7%, the gross profit (loss) margin from the sale of sheep was (17.3%) and the gross profit margin on embryo transfers was 43.9%.

Depreciation and Amortization -

Depreciation and amortization expenses were essentially unchanged compared with the corresponding period of the prior year, increasing by $3,452 to $193,619 for the three months ended September 30, 2005 compared to the corresponding period of the prior year. The increase resulted because of increased assets being depreciated.

Selling and Administrative Expenses -

Selling and administrative expenses decreased by $120,216 or 28.9% to $294,917 from $415,133 for the corresponding period of the prior year. This decrease resulted from a decrease in penalty expense of $93,878 and a decrease in management expenses of $23,329 which was offset by small decreases in other categories.


Other Income (Expense)
For the three months ended September 30, 2005 the company experienced an increase in interest income of $13,513 or 46.9% to $42,278 from $28,765. The increase is attributable to an increase in interest rates and the Company keeping a larger percentage of it's cash in interest bearing accounts.

As a result of the foregoing, the company had net income of $1,068,308 or $.03 per share for the three months ended September 30, 2005 compared to net income of $2,734,020 or $.09 per share for the corresponding period of the prior year.

Nine Months Ended September 30, 2005 As Compared to Nine Months Ended September 30, 2004.

Revenues

Revenues for the nine months ended September 30, 2005 increased by $2,076,828 or 13.6% to $17,292,310 from $15,215,482 for the corresponding period of the prior year. This increase is attributable to an increase in cattle and sheep embryo transplants of $2,128,056 and in roll mutton of $6,140,878 which was partially offset by a decrease in the sale of lamb meat of $6,326,477.

Cost of Sales -

Cost of sales for the nine months ended September 30, 2005 increased by $2,862,070 or 29.5% to $12,576,696 from $9,714,594 for the corresponding period of the prior year. This increase resulted from an increase in the costs of cattle embryo transfers of $2,177,574, of sheep embryos or $364,025 and roll mutton of $4,622,992. The increase was partially offset by a corresponding decrease in the cost of embryos of $5,600. The gross profit margin on the transfer of cattle embryos was 30.6%, the gross profit margin from the sale of mutton was 28.6% and the gross profit margin from the sale of roll mutton was 24.7%.

Depreciation and Amortization -

Depreciation and amortization expenses were essentially unchanged compared with the corresponding period of the prior year increasing by $4,052 for the nine months ended September 30, 2005 compared to the corresponding period of the prior year. The increase resulted because of increased assets being depreciated.

Selling and Administrative Expenses -

Selling and administrative expenses increased by $2,004 for the nine months ended September 30, 2005 to $1,207,100 virtually unchanged from the $1,205,096 for the corresponding period of the prior year. The increase was largely due to an increase in marketing expense which was offset by reductions in office salaries and professional fees.


Other Income (Expense)
For the nine months ended September 30, 2005 the company had interest income of $139,206, an increase of $55,591 from the $83,615 for the corresponding period of the prior year. The increase is attributable to an increase in interest rates and the Company keeping a larger percentage of it's cash in interest bearing accounts.

Interest expense was $55,152 for the nine months ended September 30, 2005, due to the Company issuing convertible debentures with a beneficial conversion feature to settle penalties for not timely meeting filing and effectiveness deadlines for a registration statement. The interest expense relates to the amortization of the beneficial conversion feature. There was no interest expense for the corresponding period of 2004.

The Company recorded an impairment loss for the nine month period ended September 30, 2004 of $53,517. There was no impairment loss recorded for the nine month period ended September 30, 2005.

As a result of the foregoing, the Company had net income of $3,017,994 or $.10 per share for the nine months ended September 30, 2005 compared to net income of $3,755,368 or $.13 per share for the corresponding period of the prior year.

Liquidity and Capital Resources

As of September 30, 2005, the Company had cash and cash equivalents of $24,164,917 and working capital of $30,948,076. This compares with cash and cash equivalents of $27,473,354 and working capital of $27,436,168 as of December 31, 2004.

Cash used in operating activities totaled $3,117,004 for the nine months ended September 30, 2005. This compares with cash provided from operating activities of $1,289,673 for the corresponding period of the prior year. This decrease resulted from a decrease in net income of $737,376 and non-cash expenses of $252,643 and changes to the current accounts which was partially offset by an impairment loss in the prior year of $53,517 and other non cash-changes.

Cash used in investing activities totaled $1,272,108 during the nine months ended September 30,2005 compared to $1,506,024 provided by investment activities for the nine months ended September 30, 2004. All of the cash from investing activities during the nine months ended September 30, 2004 was from the sale of property. All of the cash used in investment activities during the nine months ended September 30, 2005 was for the purchase of fixed assets.

Cash provided from financing activities for the nine months ended September 30, 2005, totaled $330,899 all from contributed capital. This compares with cash provided from financing activities of $78,670 for the nine months ended September 30, 2004, again all from contributed capital.

At September 30, 2005, the Company had notes payable of $443,366. These notes are currently the subject of litigation where the Company is challenging their validity.

Although the Company has a cash and bank balance of $21,329,840, it has all been designated by management for expansion of its operations within the People's Republic of China. Therefore, if the Company is to expand outside the PRC, as it anticipates doing, or pay its non-PRC obligation, it will have to sell additional shares of its stock or borrow funds from third parties. Unless it is able to either borrow funds or sell additional shares, it will have insufficient resources to carry out is business objectives outside the PRC for the next twelve (12) months.


http://biz.yahoo.com/e/051115/etlt.ob10qsb.html

I just bought in yesterday at .73...will this 10QSB have a negative effect on the pps?

Is anyone still holding this?

thanks

julia

well Julia I have mixed feelings

.....As a result of the foregoing, the company had net income of $1,068,308 or $.03 per share for the three months ended September 30, 2005 compared to net income of $2,734,020 or $.09 per share for the corresponding period of the prior year.

I have put a stop loss @ 0.71$ for today.

Just my private opinion

other feedback is appreciated

Well...unfortunately la-onda....bid and ask this am have already dropped...now i see it at .67 x.67...i guess i will start the day off with a loss :)...good luck to you.

julia

below .6  :-X
this hurts

Maybe things are turning around.... la-onda !
+18.34%.....Volume @.....434,228
Much needed !!!!!! :P

Eternal Technologies Group, Inc. Announced Today Its Preliminary Outlook for the Year-Ending December 31, 2005
Monday December 5, 9:00 am ET

HOUSTON--(BUSINESS WIRE)--Dec. 5, 2005--For the year-ending December 31, 2005, Eternal Technologies Group, Inc. (OTCBB:ETLT - News) anticipates revenues in excess of $21,000,000. This compares with revenues of $16,834,759 for the year-ended December 31, 2004. The current period will benefit from the inclusion of the financial result of E-Sea Biomedical Engineering Co. International Ltd. which will be profitable for the fourth quarter. However, the fourth quarter will not reflect any material results from the Human dairy project as most of the revenue producing activity will begin in the first quarter of 2006. The company expects earnings for the year-ending December 31, 2005 to exceed those for the year-ended December 31, 2004. The company also anticipates a significant increase in net assets from those reported as of December 31, 2004.

still out and no cash available  :-[

Apr-04-2006   Bullish Harami  ;D

http://www.stockta.com/cgi-bin/analysis.pl?symb=ETLT&num1=3&cobrand=windchart&mode=stock

feedback is appreciated  8)


blog update:

Tuesday, April 04, 2006
April 3 Update: Eternal Technologies Group (ETLT.ob) April 3 - Closing Price $0.47 USD Strong Speculative Buy - Target Price $1.38.


Overview

ETLT is an obscure microcap stock with a market capitalization of $20,238,537.57. There is only 1 institutional holder of the stock, Freedom investment corp. and they hold a mere 2000 shares.[1] ETLT trades on the OTCBB exchange; this fact, along with its small size have contributed to a lack of institutional coverage. There are currently no analysts covering the stock. The closest thing to analyst coverage that ETLT has received is a feature in "Knobias clip report". Knobias is a research organization dedicated to providing information on OTC and microcap stocks, their research coverage is not very extensive and the clip report is simply a newsletter with several pro and con points on each stock. Interestingly enough, there are some blogs on the internet that have some information and research available on ETLT.

The company is out of favour, the stock price has deteriorated from over $1.50/share in 2003 to $0.51 as of market close on March 31, 2006. The company has a history of poor communication with shareholders. Before the third quarter of 2005 the company outsourced its US investor relations to Empire Public Relations group. This agency did not provide good support to the company, and ETLT replaced them with Heron public relations group in the third quarter of 2005. Since this time, Heron has increased communications to shareholders and launched a website for ETLT, http://www.eternaltechs.com/. Nevertheless, it remains at times difficult to contact Heron and they have made no inroads into greater promotion and investor awareness of the stock. Investors are also tend to be annoyed by ETLT's tendency to file its 10-K and 10-Q filings late, a problem which plagues many listed Chinese companies.

ETLT is a conglomerate and therefore is likely subject to the discount usually present in conglomerate stocks. The stock is very cheap based on price metrics. The trailing twelve month P/E ratio is a startling 5.79. The price-to-book ratio is 0.45, based on a consolidated balance sheet of ETLT and the E-sea subsidiary. They also have $0.575/share of cash, which is more than the total market capitalization of the company. ETLT has the characteristics of a "net-net", stock, with current assets less total liabilities higher than the total market capitalization of the company. As well, performance over the last 2 years has been disappointing, with margin compression in their core business. The company is not in any significant financial distress, and interest coverage is 41.2 times EBIT.

Business Description

ETLT is in 2 distinct businesses, one of which is executed by its subsidiary E-Sea. The core business is based on agricultural genetics/animal husbandry. ETLT provides its clients, with genetically engineered breeding stock, embryos, semen and related technology and consulting services to large commercial and government farms in China. The goal of ETLT's products are to help increase clients' production yields and quality of livestock, while reduce growing costs. ETLT began providing its services by focusing on sheep breeding, but has since diversified into dairy cattle operations as well, importing embryos from Australia and US. Over time, ETLT seeks to develop a herd of genetically engineered livestock in order to produce a domestic supply of embryos. In addition to providing these services, ETLT sells sheep meat to butchers in Beijing from the sheep that it rears which are not deemed appropriate for embryo harvesting or future breeding.

ETLT also is the parent company of a 100%-owned subsidiary E-Sea which is in a different line of business, the sale of medical devices, primarily focusing on medical imaging technology. Their most interesting device and the one that seems to have the most potential is their Tri-operator Digital Mammary Gland Diagnostic System. According to the company, it is an early-stage breast cancer detection system which is 96% effective in detecting breast cancer, 2 years earlier than most competitors. E-Sea holds a Chinese patent on this device. In addition to the actual devices, E-Sea also markets medical imaging software.

Industry Analysis

Much of ETLT's core business activities are reliant upon activities and growth in the dairy industry, as well as demand for Sheep. China is currently seeing rapid and accelerating growth in dairy consumption which grew at a compound annual growth rate (CAGR) of 7.6% between 1993-2003. This accelerated between 1998-2003 to a CAGR of 10.8%.[2] Furthermore, there is still significant room for further growth in the industry. Currently China consumes 11 kg of total dairy per capita, versus a world average of almost 100 kg and 266 kg in the US. Increasing disposable income, health consciousness, distribution and government support are driving growth. According to US department of agriculture (USDA) statistics for dry nonfat milk, South Korea consumes 7 times more per capita, Taiwan 11 times and Japan 16 times.[3] The major crisis that the Chinese dairy companies face is a lack of supply of dairy cows. The dairy industry and milk consumption are growing at a faster rate than the supply of dairy cows. The Chinese government has resorted to importing dairy cows to help fulfill this need, however this has been a costly proposition as imported cows are expensive to purchase and import. ETLT is highly leveraged to growth in the dairy industry as well as a drive by the government to improve milk yields on Chinese dairy cows. According to the USDA, the yields on Chinese Dairy cows are less than half of the yield on North American cows. ETLT's cattle sale operations should perform well going forward, as the prices for dairy cattle are robust due to the shortage. Much of their success will be based on how vigorously the Chinese government seeks to expand dairy cow yields. ETLT currently has the support of the government which is a positive sign, and the current government policy has been one of promoting improved animal husbandry techniques as part of the solution to the overall cattle shortage issue.

The situation for sheep stock does not currently have the growth characteristics of the dairy cow market, however the industry has some major problems which ETLT seeks to address. Currently the wool yield on Chinese sheep is about 2 kg, compared with more than 4 kg in the U.S.[4] Thus this same yield issue exists in the sheep industry as well. The government seems eager to increase the efficiency and sustainability of its sheep production. There are currently issues regarding the sustainability of China's foraging herds, due to increased desertification of traditional pastoral lands. One part of alleviating this problem is by increasing efficiency and yields on livestock. As of 2002, sheep meat was considered a premium meat in China, with the average market price of goat meat and mutton in Beijing in 2002 was 9.64% higher than the market price of beef, or 64.2% higher than the market price of pork.[5] In addition, strong per capita income growth is spurring the consumption of meat in China. According to food and agriculture organization of the UN, average annual goat meat and mutton consumption per person in China has increased from 1.5 kg in 1996 to 2.1 kg in 2001, a CAGR of 7%.[6] The dietary trends in other Asian nations which have industrialized exhibited a shift from a carbohydrate based diet to a more protein based diet. This trend should be expected to continue in China at it continues to quickly increase its per capita GDP. In 2004, the per-capita meat intake was 49 kg in China, while that in the United States was 127 kg.[7] The agricultural services industry for sheep will move in step with sheep consumption and production. The current environment is attractive, with moderate growth and strong future potential.

The agricultural industry has traditionally been dominated by state owned farms as well as small scale semi-private farmers. A shift towards greater privatization would likely benefit ETLT, since private producers will have a greater concern for efficiency and livestock yields. In a bid to increase agricultural production and provide greater incentives to farmers and the agricultural industry, the Chinese government repealed the Agricultural Tax, a change which takes effect January 1, 2006.

With regard to E-Sea, the medical device market is growing quickly According to Frost & Sullivan, the China market for medical devices and equipment is expected to grow from US$5.9 billion in 2002 to US$10.1 billion in 2006, a CAGR of approximately 14%.[8] Hospitals and clinics are almost exclusively government run organizations, although they are generally given a large amount of operating autonomy. As a result hospitals are expected to generate enough revenue from user fees to cover between 70-90% of their operating costs. This autonomy also allows them discretion over the purchase of medical devices. The medical device industry is currently fragmented with 2,900 medical device manufacturers in China at the end of 2003.[9] Most of these manufacturers focus on low tech medical devices, and as of 2003, 85-90% of medical equipment was imported from abroad.[10] Importing these devices is quite costly, and as a result the Chinese government is encouraging the development of a domestic high-tech medical equipment industry through tax incentives. Going forward, Chinese hospitals may be more inclined to purchase Chinese medical equipment to foster the growth of the industry and also to attain cost savings.

Company analysis

ETLT benefits from government endorsement of the mission of the company and the goal of increasing overall livestock yields through superior animal husbandry techniques. In 2000, ETLT invested in an executed first transfer project in China of 10,000 fine breeding sheep embryos. It won an award in 2004 from the state ministry of education in recognition of the work executed in the sheep project as well as contributions to the advancement of breeding technology and advanced animal husbandry techniques. ETLT's operating performance has seemed poor over the last 2 years due to decreasing margins on its embryo transfer business. Gross margin has decreased from 57.7% in 2003 to 27% in 2005. This statistic is of concern, and the potential for further margin compression remains a risk to the company. Nevertheless, the previous gross margin may have been unsustainable and ETLT is still earning a healthy gross margin on the business. ETLT has also compensated for the decreased margin by increasing sales, thus keeping their overall gross income more or less stable. The increased demand for dairy cattle, and ETLT's operations in that industry may lead to an increase in gross margins from current levels. ETLT has a number of proprietary techniques for embryo transfer though it is unclear what the true level of legal protection ETLT has if someone were to infringe on their embryo transfer technology. Since most agricultural customers in the country are government companies, ETLT's reputation as the largest commercial provider of fine breeding embryos and established relationships with the government are extremely important.

E-Sea has patents on its medical devices which include: the tri-operator digital mammary gland diagnostic machine; a machine for the diagnosis and treatment for male erectile functions; an instrument for monitoring blood oxygen levels in the brain; and a medical imaging workstation. E-Sea also manages 1 breast examination clinic in the Longgang district of Shenzen and plans to open 4-6 new clinics in 2006. The fees on these examinations are paid for by the local government and the clinic has become very popular earning $68,000 in revenue and conducting over 13000 examinations after only 2 months of operations. E-Sea has signed a 6-year agreement with the local government to provide examination services to women in the district. E-Sea should be able to capitalize on this fast growing market, especially with the financial resources of ETLT behind it.

A potential cause of concern is that management only owns 2,987,000 shares, or 7.5% of the total shares outstanding. The largest shareholder is an independent investor names Shang Jiaji with 8.5% of the company. Shang Jiaji has been selling shares over the last few years, and his sales have been the cause of much of the downward pressure on the stock. On the positive side, this lack of concentration in share holdings could potentially make the company a more attractive target for acquisition.

Valuation and Risks

In valuing the company I decided to value the core business and the E-Sea business separately as they are distinct businesses operating in different industries with different growth and return on asset profiles. The company has relatively low financial risk, as there is almost no outstanding debt and over $20 million in cash on hand. Interest coverage is over 40 times EBIT. The company could potentially reduce its cost of capital by adding a debt component. There are 2 outstanding lawsuits that cover approximately $553,946 plus accrued interest and legal fees.

The business risk to ETLT has 2 separate and distinct elements. There is the actual business risk, and there is the risk of ETLT being a fraud. ETLT has a higher than average level of risk regarding compliance to securities and accounting standards. The company is listed on the OTCBB and thus the officers are subject to Sarbanes-Oxley, and US GAAP. However, since China has no extradition treaty, and the company is incorporated offshore, this company has a higher than normal risk of fraud. The share price and current market sentiment is obviously heavily discounting the possibility of fraud. A major potential but legal trading advantage exists for anyone who could spend the $1500 to take a trip to China and visit ETLT on site.

The actual business risk related to ETLT is similar in nature to most companies with operations in China. There is a potential currency risk in the case of ETLT since it buys its embryos in $USD and sells its finished product in RMB. As long as the Renminbi stays pegged within a tight band to the American Dollar, then this upside is minimized. But economists have been almost unanimous in statements that the Chinese Currency is undervalued and call for an increase in its value by 15-40%.[11] This would effect ETLT positively in the respect that its large cash position would now be worth much more in the country in which it reports, thus increasing the reported cash balance. It would also allow the company to buy high-yield embryos for a lower price, positively affecting margins. On the other hand, the revaluation would also increase the attractiveness of simply importing the necessary cattle from Western nations, which could negatively affect ETLT's embryo transfer business. The net effect of the currency risk is unknown, but it needs to be considered as a risk. There is a risk that their farmland in Inner Mongolia will be subject to the growing desertification taking place that area. The Chinese government has deemed that the land ETLT holds is not appropriate for plowing, this may harm sheep operations there. However, they have not plowed the land, so the actual effect of this may simply mean limiting any expansion of operations there. There is risk related to the ETLT's tax status. China is still an autocratic nation and there is a potential, though not imminent risk that ETLT could lose its tax free status on its core agricultural business.

E-Sea is also subject to potential currency risk, since much of the competitive landscape consists of imported medical equipment, then E-Sea would lose at least part of their price competition advantage if the Renminbi appreciates in value. This risk is mitigated somewhat by the government's endorsements and incentives given to domestic high-tech companies. There is patent infringement risk associated with E-Sea, although this is less of a problem than in the past, there is still lose patent regulation in China relative to North America. There is also the risk that due to lack of capital, E-Sea may potentially be overwhelmed by larger competitors in the market. For all these reasons I believe that ETLT has a high overall risk

In calculating the likely yield on debt that a company like ETLT would have to pay, I looked at the rates that 2 other Chinese small capitalization companies were paying on their debt: Tiens Biotech and American Dairy. American Dairy has a 5.76% non-trading note payable, as well as a short term loan from the China Construction Bank at 6.69%. Tiens Biotech has a short term note outstanding with an interest rate of 5.22%. The average of these yields is 5.90%, but I will add a size premium to ETLT's debt, since both American Dairy and Tiens Biotech are larger companies, with market capitalizations between $200-300 million. I decided on 260 basis points as a reasonable premium considering ETLT's high interest coverage, arriving at a cost of debt of 8.5%. To arrive at the cost of equity, I looked at the average equity over debt premium for a BBB conglomerate, added a size premium of 5% due to ETLT's small market-capitalization, and also added a country risk premium of 5% which yields a cost of equity of 24.54%. I also assume that due to the business risks inherent to the company, the ideal capital structure has only 10% debt. These assumptions lead to a weighted average cost of capital (WACC) of 22.81%. I believe that this high WACC adequately considers risks and the high cost of capital for a small foreign firm.



Asset Value Valuation

Both segments of ETLT's business are viable and thus the asset value should be based on reproduction values. In ETLT's core business, I believe that the reputation and relationships that ETLT has built with various levels of government in China would be costly to reproduce, I therefore capitalize marketing asset as ½ of 4 times trailing twelve month selling general and administrative (SG&A) expenses. ETLT's expertise is also significant in the areas of embryo transplant, but since they merely hold rights over a technique, rather than an actual patent, I assign their capitalized R&D asset a relatively low ½ of trailing twelve month SG&A expenses. ETLT does not have any operating leases and instead has prepaid $6,000,000 for 25 years of land usage rights on their farm in Inner Mongolia. I have not added back the amortization in order to be conservative, since the flexibility in land usage has decreased since the Chinese government deemed it illegal to plow. Property plant and equipment (PPE) represents 35,000 square foot embryo transfer center, as well as the AnBo Biotech Center a 6,450 square foot facility located in Beijing housing a laboratory facilities to support advanced biotech and embryo research and development activities. There is no reason to believe that either of these facilities is significantly impaired, so I will add back the depreciation to arrive at a replacement value. The value of the convertible note is simply the option value of its conversion, since it is non-interest bearing. Our valuation determines a net reproduction value of assets of $1.23/share for ETLT's core business.



The E-Sea asset value is relatively simple with amortization and depreciation added back to all of the fixed assets. The long term assets are less than 2 years old, so there is not likely any significant impairment of these assets. Since there is no research and development expense for the last year, I have assumed capitalized R&D asset to be equal to the book value plus amortization of their patent rights. The long term contracts and relationships with the Shenzen government are definitely valuable and I have decided to value this at 2 times ½ of normalized SG&A expense. This yields a net asset reproduction value of $0.13/share for E-Sea.



Earnings Power Valuation

Earnings for the core business were normalized by taking company guidance on revenues of $21 million and using a conservative EBIT margin of 18%. Relative to the 2004 EBIT margin of 24.6%, this is number is low, but it is close to the 17% EBIT margin that ETLT realized in the first 9 months of 2005. The earnings are assumed to be no growth earnings, since the company has not demonstrated a consistent level of growth in the past 3 years. These assumptions lead to an adjusted EPV of $0.93 for the core business.
To arrive at a no growth EPV value for E-Sea, I normalized the earnings for this year by multiplying the 6 month revenues for 2005 by 2, and taking an EBIT margin of 35%, which is less than the EBIT margin of 39% of 2005, and 53% in 2004. Our assumptions lead us to an adjusted no-growth EPV value of $0.19/share. E-Sea has displayed growth in an environment were return on invested capital (ROIC) is greater than WACC. I expect this franchise to be sustainable and therefore I have computed a value of growth of $0.08/share. I have decided to use a growth rate of 11%. Between 2001-2005 China had an average nominal GDP growth rate of 10%. I feel that due to the current lack of medical technology in China, as well as increasing income levels and health concern will allow the medical device market to grow at a faster rate than the overall economy. As mentioned earlier, experts peg this growth rate at 14%, but in the interests of being conservative, I will use 11%. With an ROIC of 40.5%, and WACC of 22.8% this gives a growth multiplier of 1.41; applied to the EPV of $0.19/share and I arrive at a value of growth for E-Sea of $0.08/share. This multiplier is sensitive to changes in the cost of capital and any reduction in the cost of capital will increase the value of the growth significantly.

Strategic Valuation Analysis

In the case of ETLT's core business, the AV is higher than the EPV, so one would expect to have an ROIC less than WACC. I have determined the ROIC of 14.3% on the core business. This is a healthy ROIC, but below the WACC of 22.81%. For this aspect of the business I have determined 2 major catalysts which could help EPV approach AV. One catalyst is improved communication to shareholders and better compliance to filing dates. The cost of equity is higher than it needs to be due to poor communication to shareholders, and consistent late filings. If ETLT improved its disclosure and communications with shareholders, the cost of equity would decrease and EPV would rise. I have given this a probability of 30%. A second potential catalyst is based on an improved demand situation, and therefore greater margins. Recently, ETLT's margins have experience compression due to higher costs and lower demand for sheep embryos. Because of the shortage of dairy cows, ETLT may be able to earn better margins as they shift their focus towards high-yield dairy cows. I have estimated a probability of this at 30% as well. This leads to a total catalyst value of $0.18/share.

In the case of E-Sea, the EPV is higher than the AV. As one would expect, the ROIC of 40.5% is higher than WACC. In the case of E-Sea it seems as though that they have a sustainable competitive advantage. They have patents on their medical devices and a captive audience. They have signed favourable, exclusive long-term contracts with the local government of Shenzen regarding the use of their equipment in clinics within that city. Their breast cancer device is unique to the Chinese market in that it detects the cancer much sooner than competitors, thus it has a significant advantage over competing products. Therefore, E-Sea will have a demand advantage as well. It is an established and recognized product, therefore an entrant would have to build up recognition and approval from doctors as well as the Chinese government. Gaining this approval can take years and potentially cost more than E-Sea spent developing it. E-Sea's recent acquisition by ETLT is also a source of competitive advantage as it will potentially be able access the large amounts of cash to expand the business that an entrant firm in China would have difficulty finding. Finally, as E-Sea continues to grow its clinic infrastructure, it will further protect itself against entry of incumbents.

Determination of intrinsic value

The intrinsic value of the ETLT core business is a product of both the underperforming EPV and the catalyst, and I calculate the intrinsic value of the core business at $1.11/share. For the E-Sea business, since I have determined it is growing in an ROIC > WACC environment, the intrinsic value is a product of the EPV and value of growth; I calculate it as $0.27/share. However the maximum price one would be willing to pay is the $0.19/share EPV. This implies a total intrinsic value of $1.38, representing a 63% margin of safety based on current stock price of $0.47. This 66% margin of safety implies 194% upside.


Risk Management Assessment

For ETLT's core business, one must carefully watch the cash position as this is the source of so much of ETLT's intrinsic value. ETLT's performance has deteriorated due to greater costs in their sheep embryo business. This has been mitigated with increased revenues, however further deterioration of margins would harm the business. Although ETLT's business has deteriorated somewhat, this risk is mitigated by the abnormally large margin of safety on the stock. The large margin of safety also mitigates the risk that E-Sea does not live up to the growth expectations, since even if I exclude the value of that business entirely I would still arrive at an intrinsic value of $1.11, which still provides a margin of safety of 54%. In this case the margin of safety minimizes downside risk.

Opinion

Based on abnormally large margin of safety and a cash position exceeding market capitalization, I recommend a buy on this stock at the current price. Before placing a large amount of money in the company perhaps a trip to China could be arranged to actually view the facilities and confirm that nothing fraudulent is happening. In the absence of fraudulent activity, this stock is extremely undervalued, and has on a conservative basis has almost 200% upside potential.

http://harbinus.blogspot.com/

Hi la-onda
Just some feed-back on ELTL . As you know pennys are the hardest thing in the world to predict but this is only only my opinion . I have noticed one thing about pennys while keeping a close eye on them since elite has picked some really good ones lately.
They have big names associated in their PR's from contracts they are posting and if the PR's wasn't for real the big name company's could get them in a lot of trouble for this. I never pick a stock that willn't give me a profile of it,Why won't they let someone see their profile. Also
another lesson learned from elite. Volume,,,volume,,volume has got to show investors are interested. Stocks with low volume are very hard to dump if trade goes bad.
Like I said it's just my opinoin and everyone one who plays this game must consider the amount of risk they are willing to take when intering a position especially with pennys.
Hope you have a great trading day

Does anyone have any feedback on ETLT.

At 37 c a share this has taken a huge beating and the YE results should come out either today or tomorrow as per PR firm I just called.

NAV per share must be USD 1.20 or thereabouts.

Some OS tax issues

Any comments are truely welcome...

wow..too many threads on ETLT..i just picked the top...tired of having to look in each one to see which one was the original...wish the date of the first post was visible when doing the search, rather then the last post on the thread.

Anyways...nice revs news caused a healthy move here. Watch to see if it continues to break the last high and hold over.

Wednesday, November 15 2006 11:55 AM, EST

Eternal Technologies Announces Third Quarter Results

Business Wire    "US Press Releases "

HOUSTON--(BUSINESS WIRE)--

Eternal Technologies Group, Inc. (OTCBB:ETLT) today reported results of operations for the three and nine months ended September 30, 2006.

Revenues for the three months ended September 30, 2006 increased by $2,089,207 or 41.6% to $7,116,175 from $5,026,986 for corresponding period of 2005. For the three months ended September 30, 2006 the company had net income of $1,843,743 or $.05 per share compared to net income of $730,231 or $.02 per share for the corresponding period of the prior year.

For the nine months ended September 30, 2006, the company reported revenues of $21,702,671, an increase of $4,443,288 or 25.7% from the $17,259,383 reported for the nine months ended September 30, 2005. The company had net income of $4,043,242 or $.10 per share for the nine months ended September 30, 2006 compared to net income of $2,560,091 or $.06 per share for the corresponding period of 2005.

The Company continues to be very liquid. As of September 30, 2006, it had cash and cash equivalents of $14,891,671, short term investments of $25,262,732 and working capital of $39,692,110. The company's shareholders equity increased to $53,340,660 or $1.31 per share, substantially above its closing price of $.0467 on November 14, 2006.

Mr. Jijun Wu, Chairman of the company, stated that "the company is performing and continues to perform very well, exceeding its projections in all of its operations. He went on to state that the results of E-Sea are particularly encouraging, as E-Sea has generated $5,761,636 in sales for the first nine months with a gross profit margin in excess of 60%. He concluded by stating that the company expects to have record operating results for the year ended December 31, 2006.

The company's financial statements for the three and nine months ended September 30, 2006 are attached hereto.

About Eternal Technologies

Eternal is a major agricultural genetics and biopharmaceutical R&D firm operating in China with the support of the Chinese Government. Eternal's animal breeding division has a strong asset base, cash position and net income. Eternal has become one of China's leading institutions for biopharmaceutical and biotech research, pure breed cultivation and breed stock production. The Company has secured a key market niche by commercializing gene engineering technologies and providing superior breeding stock, allowing China's citizens the ability to improve their living standards. With the world's largest population, a double-digit national growth rate and entry into the WTO, Eternal Technologies has a playing field set for tremendous opportunity. As a prominent player in the agricultural genetics industry, cash in the bank and an untapped market, Eternal has the potential to become a major player in China's national growth.

    For more information please visit website: www.eternaltechs.com
                   ETERNAL TECHNOLOGIES GROUP, INC.

Julia posted the news, ;)
Eternal Technologies Announces Third Quarter Results
Good report...... market reacting favorably !  ;D
There are a number of future events... catalysts for this company.
This is why the stock will trade less and less like a OTCBB stock in the future.

52wk Range: 0.35 - 0.69
Volume: 2,615,363........ ;D
Avg Vol (3m): 182,202

Technicals ........ ;)
13-day EMA Cross Above 50-day MA
Close Above the 50-day MA
Close Above the 13-day MA
Percentage Gainer

Last Price Quote is:
21.43%above 13-day MA
24.23%above 50-day MA
RS Rating: N/A 

Fundamentals
Reports Earnings

Key Data:
Market Cap (M): N/A 
P/E Ratio: N/A 
PEG Ratio: N/A 
Next Earnings: N/A
Last Analyst Rating: N/A

Dang...i had this on my watch list too and failed to buy the gspot breakout..grrrr..i was distracted and missed it.

An S-8 was issued this am FYI

Terliso....ur 3 magic lines are workign it here. :)

heating up today.  up 7.61%

ETLT update (6.2.07) from their webpage:

A)
Major Strategic Investments   (6-Feb-2007)

１.
Invest US$37 million for breeding US fine breed dairy cattle. The project consists of two parts. In the US, we will establish a plant for producing fine breed dairy cattle embryos. In China, we will purchase local cattle as recipients, rent lakeside grassland, and build modern stables and facilities to initialize setup of livestock production.

２.
Acquire medical equipment company – E-Sea International. It is the only company in China to own the exclusive technologies of digital mammary gland detector. The detector is able to locate cancer 2 years earlier than other devices. The accuracy reached 96%. Breast cancer, following lung cancer, is the second frequently occurred cancer among women. According to World Health Organization, 1.2 million people were diagnosed breast cancer during 2004. The earlier the breast cancer is identified, the better it is for treatment. World Health Organization launched a program to control breast cancer. Various women organizations in China are providing special examinations for millions of women each year. These programs create a market for promotion, application, and update of the digital mammary gland detector.

３.
Acquire a medical marketing network – Shenzhen *** Drug Store Management Co., Ltd. and enter marketing area for medical products. The company is promoting a membership to integrate medium and small medical retailing companies and set up a joint purchase platform. The goal is to lower purchase cost and to make member companies more competitive. It has 40 member companies in 20 provinces and cities. There are 4,000 drug stores under such companies.

４.
To develop hi-tech products – Digital Medical Technology. Electromagnetic data are collected at acupoints on human body. The health status of the patient can be obtained by analyzing the balance of the electromagnetic system and then be compared with standard models so that abnormal areas are located. Adjustments and treatments will focus on the abnormal areas. This technology can be used extensively in diagnosis, treatment, and health care.

５.
Expand to Southeast Asia. We are going to pursue opportunities to expand ETLT business into Southeast Asian markets by building key business contact based on geographic advantages.

link:
http://www.eternaltechs.com/ShowPrespective.asp?id=54

&

B)

Strategic Transitions   (6-Feb-2007)

１.
Relocate to Southern China where resources are more abundant compared to the harsh Northern climate

２.
Build from original agriculture development methods to highly sophisticated leading edge technologies

３.
Expand the business internationally to capture key global market

link:
http://www.eternaltechs.com/ShowPrespective.asp?id=53

An interesting post from Raging Bull. Any thoughts?

---
http://ragingbull.quote.com/mboard/boards.cgi?board=ETLT&read=7004

By: stanu78 
10 Jan 2007, 12:24 PM EST

My take on ETLT (mainly for newbies. I thought I post it here too).

Supposedly their numbers speak for itself (provided the numbers are real).Eternal Technologies (ETLT.OB)

Company Website : http://www.eternaltechs.com
Market Cap : $23M-$24M
Share price : $0.57-.$0.60 (recent price)
Diluted outstanding : about 40M shares
Preferred outstanding: 0
Cash + ST investment : $40M ($1 per share) (mostly restricted cash)
LT Debt : $0
Earning : $4M+ (and has been profitable for several years)
Retained earnings : $35M
Sales : $23M
PE : 6
Book value : $53M ($1.3 per-share)
Tangible book value : $47M
P/tangible book : < 1

ETLT is based in China. I would call them a conglomerate business (diversified business). They deal mostly agriculture industry (except the breast cancer first screening/detection business i.e. E-Sea) and looking to enter some other industry (such as microdisplay business). Their agriculture business area also diversified ranging from meat and embryo business, to mango planting and turtle breeding project (the latest on is a very new venture owning 22% of a turtle breeding project). The embryo and meat business is slowing down therefore (which is not the sole cause) they are looking for other new businesses to invest (as they want to grow plus they have ample cash to use).

ETLT stocks has been low (low valuation) for a long time even the company performance has been great ($4M+ earning per year while building more cash balance) and there is no guarantee (nor that I am confident) that it will be any different in 2007

ETLT valuation is so low that many people think it is a fraud. I heard many people said that ETLT is cheaper or better buy at $1 or $2, which doesn't seem to make sense to me (I ask ed them and they explain that by that price there surely will be more info/ more people confident with the company)
The other scenario is maybe it is indeed a fraud (as some investors told me that some of ETLT key management used to be with CHCL), therefore the stock is always what it is (super low valuation). and what funny is, even those who believe ETLT is a fraud thinks it will touch $2 before eventually go to $0 (and some did buy though believing there is a huge chance of fraud). Weird isn't it.. ?

Some other concern that many investors had:
The nice cash position is restricted cash (can only be used in PRC) since they get favorable tax treatment (no income tax for their agricuture business for many years to come which is nice ). This restricted status has been questioned by many investors, as to, "does the cash really exist if they can't be used outside China?" and the question whether the cash can be used to buy back shares or pay dividend (basically returning the cash to the owner/shareholder) was never answered clearly/directly. So does shareholder (us) really own the company, their cash and their asset? I'd let you be the judge..

As for me, I'm giving ETLT management the benefit of the doubt that this time around they will do the right thing and will eventually bring value to the Shareholder.

Stan
PS: This is not a recommendation for an investment. Investment in ETLT is risky and you can lose all your investment. As a disclosure, I'm holding about 120K shares of ETLT in my microcap portfolio at average cost of .49 per share, so if ETLT goes under, I will lose some money too (I'm putting my money where my mouth is).
----

S.T.E.P.S entry?


...also, several threads could be merged.


Jody

 ??? ???Oh crap, this has got to be some kind of record.   ??? ???

"ETLT.OB" Threads have been Merged.
Please use the search before starting new threads on a Stock Pick.
Chances are a thread already exist.
So why not post whatever you have to comment about on that pick to that thread.
"Simplicity" My fellow traders.   ;D                           
All history on a stock pick in 1 thread is awesome.     ;)                       
Just trying to get threads together,so we don't have a numerous amount floating around on the same stock.   :(     
Thank You....and good luck with all your trades....make some $$$       ;)     

Some news today and a LOT of volume.

Eternal Technologies Group, Inc. Reports Record Revenues and Record Earnings for the Year-Ended December 31, 2006
http://biz.yahoo.com/bw/070403/20070403005870.html?.v=1 (http://biz.yahoo.com/bw/070403/20070403005870.html?.v=1)

Chart is a 2yr weekly...

the weekly chart is showing an approaching Golden Cross...on the monthly, however, it looks like it may want to test the 200dma?

Any thoughts?

ETLT.ob looking very strong as of late.  There was an overreaction to the fact that they asked for an extension in the latest earnings report.......numbers looked good overall.  We'll be off to new highs by the end of year.

I added on the 200 day retest and am still holding...back above 9sma

Chart update:

Is ETLT.ob on fire?  No!  But lets call this technique "bottom fishing"!

ETLT.ob just went down testing again a 2 years ascending trendline.

My take is,...  this trendline looks strong enough to hold another few months, even a full year

Doing the math, I notice, this trendline for 2 years had a slope of 0.23$ per year!

If ETLT.ob hold for another year this trendline,
we will all do very well in 12 months time---> 38,33%

Even half a year would do for me!(19,16%)

Getting in at 0.60 today will provide you with a brilliant return of 38,33% as long as ETLT doesn't cross the support line during the entire year.

   0.23 / 0.60 * 100 = 38,33%

If the trend goes against us, I would sell below 0.545$,
so this would be accounted for a maximun of 10% lost
the 38,33% gain in 12 months time gives us a confortable gain/lost ratio of 3,8!

Good luck all!

Here is the friday update of the 3 years chart for ETLT.ob

Did you notice in the last 6 days  the insistence of ETLT.ob 
to stay over the 0.60$ mark at the closing day?

The chart shows than the last 2 years
July - August period was the lowest of the year...

Are the traders on holydays
or just a bit of weakness from the 2° financial quarter???

Any opinion is welcome!

Good move...

Wow, way undervalued, this is a sure double in a month or so. My DD pegs this stock as an extreme buy. It should be worth twice as much right now so I give the market a month to find and buy this stock and correct it to its real value.

still looking good...

Is this a G-pattern breakout?

Quote from: 422fwhp on October 10, 2007, 03:52:31 PM
Is this a G-pattern breakout?

...the big picture:

Boooya!

3 magic lines...

Still holding up above the 9dma...any others in?

If the market assessed this company appropriately right now, we would be looking at $1.80 stock. As a value investor I have no doubt the street will price this right eventually but there needs to be more eyeballs to see what a lot of us here see already.

Currently oversold! Moving out of the over sold position, will make when volume picks up. Be on the watch and look at the charts. Company makes money and has been undervalued during market sell off. Buy before the pop. I have calculated this to be at 1.80 shortly if market notices this stock and values it correctly. Look at the financial  and you will see what I have been looking at since 50 cents.

Chartists must look at the hammer that formed a bottom yesterday plus it is moving out of the oversold condition nicely. Buying pressure will pop the stock up to new highs so be sure to buy a few shares while its cheap. Again this is a double in the short term.

Very bullish signal on the MACD! Moving out of the oversold area which is the buy signal for any stock on a technical basis. Ill say it then, ITS TIME TO BUY! :)

Homework this company. You will be surprised at how strong their revenue is and their growth. Currently trading sideways. Good time to buy because its north from here. Consolidating its base and then it will get momentum. Look at my other stock ERFW, momentum has hit after trading sideways for a couple of weeks. Find a company you believe in, plunge as many shares as you feel comfortable and hold it! Thats where the big money is at.

buying more at these levels. oversold and highly such a bargain. for new investors please do your DD so you will know how good this company is at this price so as not to be shaken out so easily. We will be make new 52 week highs in just a moment just watch. The market is ignoring this little gem.

still oversold. Trying to get more in the low 70s

Technicals are back! Take a look for yourself. Will probably close above the 50 ma again so this could be a great reversal signal. GL

Although I don't disagree...I think you post too much, like a pumper does...jmo

I only post when I see a rise coming thats all. I get excited! Plus I was the only one doing it so I had to talk to myself. So you'd rather I post once a month?

Haha....that's funny.

Well maybe I'm referring to the statements about it being oversold (which it hasn't been since early Aug) and "now moving out of oversold" and "bullish MACD signal" on it's way down which made me laugh.

Although MACD looks to be turning NOW at near zero levels and could also be a "3magic lines" setup...backed up with a chart...

Not convinced it's ready just yet...it may need a bit more time to develop, IMO.

But it sure looks like it could be getting close.

Did a little DD on ETLT over the weekend and this is why I will not sell a single share:
-47% increase in revenue QOQ
-Acid Test ratio (how well it can pay off debt) is 20.39. The common company only logs in 0.3 in which the market see's 1 and up as good. This is outstanding.
-Free Cash QOQ is 46.65%. Amazing. I looked back to only the last 4 quarters this weekend and each of those quarters has risen. This is what you look for.

Just thought I'd share the reason why I am buying as much as I can hold of 1 stock.
Do your own DD and you too will appreciate this companies financial. Current trading at a very attractive price.

A reminder that there is no way a strong company like this should be at these levels in comparison to other companies that make no money. ETLT went from 16 mill to 26 mill in cash and cash equivalents. Thats $26 million in liquidity they can use right now to grow the business. There are soo many stocks out there that sometimes the good ones get buried under all the rubbish, but once the street gets wind of it, it will ALWAYS value the company at its appropriate price eventually. The time when it will do so is the only variable.

Revenues for the three months ended June 30, 2007 increased by $713,872 or 6.9% to $11,084,009 from $10,370,137 for the three months ended June 30, 2006. Revenues for the six months ended June 30, 2007 increased by $4,198,000 or 27.4% to $18,588,494 from $14,586,496 for the six months ended June 30, 2006.

Net income for the three months ended June 30, 2007, increased by $260,641 or 15.7% to $1,919,341 compared to $1,658,700 for the three months ended June 30, 2006. For the six months ended June 30, 2007 net earnings increased by $932,583 or 42.4% to $3,132,082 from $2,199,499 for the six months ended June 30, 2006. Net earnings per share were $.04 for the three months ended June 30, 2007 and $.07 for the six months ended June 30, 2007.

As of June 30, 2007, the company had $41,961,172 of cash and certificates of deposit or $.89 per share in cash and certificates of deposit. In addition, as of June 30, 2007 its book value exceeded $1.34 per share. As of June 30, 2007, the company also had $45,015,627 of working capital or nearly $.96 per share while total indebtedness was only $2,318,574, the company's total assets as of June 30, 2007 were $65,546,840.

This is a cash cow for longs. Superb company. At the current PPS levels, its a complete bargain if I ever saw one. Do your own DD and you won't be able to not buy shares. Happy Trading.

Tough break on the earnings their.  I guess on the brightside thats an ok looking hammer.